LevelsRx Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7/10
Best for: people wanting oral or injectable glp-1 with a weight-loss money-back guarantee
LevelsRx is a solid telehealth option with balanced features and pricing.
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
LevelsRx is a US direct-to-consumer telehealth offering compounded GLP-1 weight-loss medication, including compounded semaglutide (injectable and an oral liposomal liquid) starting at 150 dollars per month and compounded tirzepatide starting at 240 dollars per month, plus Sermorelin. Care is fully virtual with licensed providers, same-day slots, and unlimited online visits, and the program advertises a weight-loss money-back warranty if targets are not met. Compounded meds are not FDA-approved. Support is by phone and email with 24-7 availability.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to LevelsRx
MEDVi
Best for: patients who want the option to switch between compounded and brand-name GLP-1 through one provider
Editorial score · methodology
Liv Body
Best for: compounded GLP-1 paired with a muscle-preservation supplement stack
Editorial score · methodology
DudeMeds
Best for: men seeking no-fee GLP-1 access with oral and injectable options
Editorial score · methodology
LevelsRx at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $150/mo (Injectable or oral liposomal liquid; starting price)
- Pricing model
- Scales with dose — higher doses cost more
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letter on record
How we scored LevelsRx
Each dimension is scored algorithmically from LevelsRx’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
7.5/10At $150/mo, LevelsRx runs about 12% below the $170 median for GLP-1 providers. Note the price scales with dose, so budget for higher tiers as you titrate.
Effectiveness25%
7.6/10LevelsRx offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes. An oral/needle-free option is offered for patients who avoid injections.
User Experience15%
7.2/10Online intake and platform experience — ongoing clinician messaging, consult included in the price; 6 platform features disclosed.
Trust & Safety15%
6.7/10Core details confirmed by our editors; no FDA warning letters on file (last checked 2026-07-16).
Accessibility10%
5.5/10LevelsRx's exact state footprint isn't published — confirm coverage in your state before signing up.
Support10%
5.8/10Clinician messaging between visits.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this LevelsRx review
Last checked July 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
GLP-1 medications LevelsRx offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Injectable or oral liposomal liquid; starting price
Starting price; injectable
Ready to get started?
Plans and promotions change often — check LevelsRx's current pricing and active discounts before you decide.
What we like
- Both injectable and oral semaglutide plus tirzepatide, with same-day virtual visits
- Weight-loss money-back warranty if targets are not met
- 24-7 phone and email support with unlimited online provider visits
Watch-outs
- Compounding pharmacy is not named publicly
- States served are not published on the site
- Prices are 'starting at' figures that may rise with dose
Is LevelsRx worth it? Our verdict
LevelsRx positions itself around one thing: people wanting oral or injectable glp-1 with a weight-loss money-back guarantee. It runs $150/month — toward the affordable end of the market. Its standout is a needle-free oral option, which very few providers offer.
What gives LevelsRx its own flavor: Money-back guarantee and 24/7 support.
How much LevelsRx actually costs
- Compounded semaglutide — $150/month
- Compounded tirzepatide — $240/month
That puts LevelsRx below the roughly $170 median ongoing price across the GLP-1 providers we track — a real cost advantage.
For a direct comparison, SkinnyRx runs semaglutide and tirzepatide from $149.25/month — worth pricing against LevelsRx before you commit.
Medications: what LevelsRx prescribes
LevelsRx prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two molecules with the strongest published weight-loss trial outcomes. The medication is compounded at a licensed pharmacy rather than sold as a brand pen, which is what keeps the price down. The trade-off is the one every compounded provider shares: compounded drugs aren't FDA-approved as finished products.
LevelsRx's needle-free oral option is a real draw if you've been avoiding a GLP-1 because of injections. Just set expectations on the science: oral and buccal delivery of these peptides is far less studied than the injectable versions the trials used, so treat it as a convenience option rather than a proven equal to the shot.
Who LevelsRx is best for — and who should skip it
A good fit if you…
- are focused on the lowest ongoing monthly cost.
- are needle-averse and want a non-injectable option.
- value being able to message a clinician between visits.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen.
- need to bill insurance — like most of this market, it's cash-pay.
Trust, safety, and medical oversight
LevelsRx offers clinician messaging between visits. We found no FDA warning letters on file for the provider. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
LevelsRx earns its place on the shortlist mainly on price: at $150/month it's one of the more affordable ways to stay on a GLP-1, without obvious corners cut on access or oversight.
The Bottom Line
LevelsRx is a solid telehealth option with balanced features and pricing.
Ready to start with LevelsRx?
Starting at $150/month. See current pricing and start your free consultation.
LevelsRx might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
- If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider GobyMeds.
- If the lowest possible monthly price is your top priority, consider Sesame Care (from $59/mo).
- If you want built-in coaching and behavior-change support, consider MEDVi.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this LevelsRx review:
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See LevelsRx's current pricing
Plans start at $150/month. Start your free consultation to check eligibility and today's price.